0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial | 
Marc S. Sabatine, MD, MPH
JAMA. 2016;315(23):2525-2526. doi:10.1001/jama.2016.6110.

Original Investigation | 
Peter Ganz, MD; Bettina Heidecker, MD; Kristian Hveem, MD, PhD; et al.
JAMA. 2016;315(23):2532-2541. doi:10.1001/jama.2016.5951.
Includes: Supplemental Content

Viewpoint |  FREE ONLINE FIRST
Samia Mora, MD, MHS; Jeffrey M. Ames, BS, MEng; JoAnn E. Manson, MD, DrPH
JAMA. Published online June 20, 2016. doi:10.1001/jama.2016.8362
Includes: Supplemental Content

Viewpoint | 
JoAnn E. Manson, MD, DrPH; Chrisandra L. Shufelt, MD; James M. Robins, MD
JAMA. 2016;315(21):2273-2274. doi:10.1001/jama.2016.3676.

Viewpoint |  FREE ONLINE FIRST
Thomas R. Frieden, MD, MPH
JAMA. Published online June 01, 2016. doi:10.1001/jama.2016.7992

Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2016;315(20):2159. doi:10.1001/jama.2016.5372.

Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2016;315(20):2159. doi:10.1001/jama.2016.6212.

Original Investigation | 
Katherine T. Mills, PhD; Jing Chen, MD; Wei Yang, PhD; et al.
JAMA. 2016;315(20):2200-2210. doi:10.1001/jama.2016.4447.
Includes: CME, Supplemental Content

Editorial |  FREE ONLINE FIRST
Aram V. Chobanian, MD
JAMA. Published online May 19, 2016. doi:10.1001/jama.2016.7070

Original Investigation |  FREE ONLINE FIRST
Jeff D. Williamson, MD, MHS; Mark A. Supiano, MD; William B. Applegate, MD, MPH; et al.
JAMA. Published online May 19, 2016. doi:10.1001/jama.2016.7050
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA Dermatology
Observation  | 
Management of Antiplatelet Allergy After Cardiac Stenting
Nicole Fett, MD, MSCE
JAMA Cardiology
Brief Report  | 
Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure
Gregg C. Fonarow, MD; Adrian F. Hernandez, MD, MHS; Scott D. Solomon, MD; et al.